Die München Klinik Neuperlach ist ein Krankenhaus der Maximalversorgung der München Klinik gGmbH im Münchener Stadtteil Neuperlach und akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München.

During the past decade, Klinikum Neuperlach conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Neuperlach" #1 sponsor was "Helsinn Healthcare SA" with 4 trials, followed by "Egetis Therapeutics" with 2 trials sponsored, "Aileron Therapeutics, Inc." with 1 trials sponsored, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Neuperlach" #1 collaborator was "Parexel" with 2 trials as a collaborator, "Solasia Pharma K.K." with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Neuperlach" are "Colorectal Cancer" (3 trials), "Coronary Artery Disease" (3 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Chemotherapy-induced Nausea and Vomiting" (2 trials) and "Chemotherapy-induced Peripheral Neuropathy" (2 trials). Many other conditions were trialed in "Klinikum Neuperlach" in a lesser frequency.

Most popular intervention types in "Klinikum Neuperlach" are "Drug" (14 trials), "Other" (3 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Calmangafodipir (5 µmol/kg)" (2 trials), "Dexamethasone" (2 trials), "ALRN-6924" (1 trials) and "CRT-D implantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Neuperlach" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Neuperlach". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Klinikum Neuperlach, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Neuperlach, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".